Saladax Biomedical Acquired Intellectual Property Portfolio of Antipsychotic Drug Testing from Janssen Pharmaceutica NV

In April 2022, Saladax Biomedical, Inc. acquired a patent portfolio for antipsychotic drug testing from Janssen Pharmaceutica NV. The IP portfolio includes the 17 patent families and has resulted in 33 US and 296 patents in ex-U.S. countries. With this IP portfolio, Saladax develops tests for chemistry analyzers commonly found…

In April 2022, Saladax Biomedical, Inc. acquired a patent portfolio for antipsychotic drug testing from Janssen Pharmaceutica NV. The IP portfolio includes the 17 patent families and has resulted in 33 US and 296 patents in ex-U.S. countries. With this IP portfolio, Saladax develops tests for chemistry analyzers commonly found in hospitals and a point-of-care instrument that can be used where centralized testing is not possible. With this acquisition, Saladax Biomedical has strengthened its position in the drug testing space.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX